January 2014
Conference Coverage: Diabetes Innovation
Conference Coverage: Diabetes Innovation
Study Finds African Americans Less Likely to See Obesity as Harmful to Quality of Life
A Protein Directs Appetite Suppressor in the Brain; Could Guide Obesity Treatment
Approximately 80% to 90% of Patients Diagnosed With Type 2 Diabetes Mellitus Are Also Obese
Conference Coverage: Diabetes Innovation
Advertisement
Advertisement
Trending on AJMC
1
FDA Clears First Alzheimer Blood Test for Adults as Young as 40
2
MFN Drug Agreements Could Raise Prices Worldwide
3
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
4
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
5